Background: Biomarkers are indispensable tools for screening, diagnosis, and prognosis in cardiovascular diseases and their clinical application increases steadily. As cardiovascular diseases include various pathophysiological processes, no single biomarker, even natriuretic peptides, can be regarded as ideal ...
However, asingle "all-in-one" biomarker that fits all-surveillance,diagnosis, prediction of prognosis-has not been foundso far. The future of biomarkers most probably lies in acombination of non-invasive biomarkers, imaging andclinical parameters in a surveillance setting. Molecularprofiling of ...
Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjo¨ gren's syndrome. Ann Rheum Dis 2015; 66:351-357. This is the first clinical trial to demonstrate the efficacy of B-cell depletion in SjS. This article highlights...
BP-Lowering Efficacy of the Second-Generation RF Ablation System Other RDN Ablation Systems Comparison of Ultrasound and RF Ablation Biomarkers to Evaluate the Extent of RDN Reinnervation After RDN Future Directions of RDN References Figures (9) Show 3 more figures Tables (1) Table 1JACC...
76 pubmed google scholar crossref 136. hageman gsluthert pjchong vnhjohnson lvanderson dhmullins rf an integrated hypothesis that considers drusen as biomarkers of immune-mediatedprocesses at the rpe–bruch's membrane interface in aging and age-relatedmacular degeneration. prog retin eye res. ...
Nevertheless, two large, randomized, multicenter trials on epilepsy prevention in TSC, EPISTOP ("Long-term, Prospective Study Evaluating Clinical and Molecular Biomarkers of Epileptogenesis in a Genetic Model of Epilepsy - Tuberous Sclerosis Complex", ClinicalTrials.gov NCT02098759, ended in April ...
The analysis of biomarkers in biological fluids, also known as liquid biopsies, is seen with great potential to diagnose complex diseases such as cancer with a high sensitivity and minimal invasiveness. Although it can target any biomolecule, most liquid
However, there are still many unanswered questions for optimizing adjuvant systemic therapy for resectable NSCLC. First, several molecular risk stratification assays and novel cancer biomarkers, independent of clinical characteristics, are available to determine the risk of cancer recurrence and select high...
Systems biomarkers in psoriasis: Integrative evaluation of computational and experimental data at transcript and protein levels Gene, 647 (2018), pp. 157-163, 10.1016/j.gene.2018.01.033 View PDFView articleView in ScopusGoogle Scholar [91] L. Lalor, M. Titeux, F. Palisson, I. Fuentes, M....
Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy Am. J. Pathol., 175 (2009), pp. 808-816 View PDFView articleCrossrefView in ScopusGoogle Scholar [16] N. Normanno, A. Rossi, A. Morabito, S. Signoriello,...